nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—dilated cardiomyopathy	0.616	1	CbGaD
Lapatinib—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0733	0.409	CbGbCtD
Lapatinib—ABCB1—Lisinopril—dilated cardiomyopathy	0.0563	0.314	CbGbCtD
Lapatinib—ABCB1—Spironolactone—dilated cardiomyopathy	0.0496	0.277	CbGbCtD
Lapatinib—TAP1—cardiac ventricle—dilated cardiomyopathy	0.00608	0.0988	CbGeAlD
Lapatinib—TAP1—myocardium—dilated cardiomyopathy	0.00572	0.0929	CbGeAlD
Lapatinib—PIK3C2B—cardiac ventricle—dilated cardiomyopathy	0.00571	0.0927	CbGeAlD
Lapatinib—PIK3C2B—myocardium—dilated cardiomyopathy	0.00537	0.0872	CbGeAlD
Lapatinib—PI4KB—cardiac ventricle—dilated cardiomyopathy	0.00416	0.0676	CbGeAlD
Lapatinib—TAP1—heart—dilated cardiomyopathy	0.00399	0.0649	CbGeAlD
Lapatinib—PI4KB—myocardium—dilated cardiomyopathy	0.00391	0.0635	CbGeAlD
Lapatinib—PIK3C2B—heart—dilated cardiomyopathy	0.00375	0.0609	CbGeAlD
Lapatinib—TAP1—cardiac atrium—dilated cardiomyopathy	0.00341	0.0555	CbGeAlD
Lapatinib—PIK3C2B—cardiac atrium—dilated cardiomyopathy	0.0032	0.0521	CbGeAlD
Lapatinib—PIK3C2B—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.00313	1	CbGdCrCtD
Lapatinib—ERBB2—heart—dilated cardiomyopathy	0.00291	0.0474	CbGeAlD
Lapatinib—ERBB4—heart—dilated cardiomyopathy	0.00291	0.0474	CbGeAlD
Lapatinib—PI4KB—heart—dilated cardiomyopathy	0.00273	0.0444	CbGeAlD
Lapatinib—ERBB4—cardiac atrium—dilated cardiomyopathy	0.00249	0.0405	CbGeAlD
Lapatinib—EGFR—heart—dilated cardiomyopathy	0.00247	0.0401	CbGeAlD
Lapatinib—PI4KB—cardiac atrium—dilated cardiomyopathy	0.00233	0.0379	CbGeAlD
Lapatinib—Gefitinib—EGFR—dilated cardiomyopathy	0.00221	1	CrCbGaD
Lapatinib—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00158	0.0492	CcSEcCtD
Lapatinib—Alopecia—Spironolactone—dilated cardiomyopathy	0.000894	0.0278	CcSEcCtD
Lapatinib—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000789	0.0245	CcSEcCtD
Lapatinib—Dehydration—Furosemide—dilated cardiomyopathy	0.00074	0.023	CcSEcCtD
Lapatinib—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000719	0.0223	CcSEcCtD
Lapatinib—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000647	0.0201	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000621	0.0193	CcSEcCtD
Lapatinib—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000597	0.0186	CcSEcCtD
Lapatinib—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00058	0.018	CcSEcCtD
Lapatinib—Dehydration—Lisinopril—dilated cardiomyopathy	0.000555	0.0173	CcSEcCtD
Lapatinib—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00053	0.0165	CcSEcCtD
Lapatinib—Pruritus—Spironolactone—dilated cardiomyopathy	0.000509	0.0158	CcSEcCtD
Lapatinib—Angiopathy—Furosemide—dilated cardiomyopathy	0.0005	0.0155	CcSEcCtD
Lapatinib—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000497	0.0155	CcSEcCtD
Lapatinib—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000492	0.0153	CcSEcCtD
Lapatinib—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000483	0.015	CcSEcCtD
Lapatinib—Malnutrition—Furosemide—dilated cardiomyopathy	0.000479	0.0149	CcSEcCtD
Lapatinib—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000463	0.0144	CcSEcCtD
Lapatinib—Vomiting—Spironolactone—dilated cardiomyopathy	0.000457	0.0142	CcSEcCtD
Lapatinib—Rash—Spironolactone—dilated cardiomyopathy	0.000453	0.0141	CcSEcCtD
Lapatinib—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000453	0.0141	CcSEcCtD
Lapatinib—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000451	0.014	CcSEcCtD
Lapatinib—Headache—Spironolactone—dilated cardiomyopathy	0.00045	0.014	CcSEcCtD
Lapatinib—Anaemia—Furosemide—dilated cardiomyopathy	0.000443	0.0138	CcSEcCtD
Lapatinib—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000435	0.0135	CcSEcCtD
Lapatinib—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000434	0.0135	CcSEcCtD
Lapatinib—Leukopenia—Furosemide—dilated cardiomyopathy	0.000429	0.0133	CcSEcCtD
Lapatinib—Nausea—Spironolactone—dilated cardiomyopathy	0.000427	0.0133	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000405	0.0126	CcSEcCtD
Lapatinib—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000391	0.0122	CcSEcCtD
Lapatinib—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000384	0.0119	CcSEcCtD
Lapatinib—Skin disorder—Furosemide—dilated cardiomyopathy	0.00038	0.0118	CcSEcCtD
Lapatinib—ABCB1—heart—dilated cardiomyopathy	0.00038	0.00617	CbGeAlD
Lapatinib—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000375	0.0116	CcSEcCtD
Lapatinib—Anorexia—Furosemide—dilated cardiomyopathy	0.000373	0.0116	CcSEcCtD
Lapatinib—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000372	0.0116	CcSEcCtD
Lapatinib—Alopecia—Lisinopril—dilated cardiomyopathy	0.000365	0.0113	CcSEcCtD
Lapatinib—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000362	0.0112	CcSEcCtD
Lapatinib—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00036	0.0112	CcSEcCtD
Lapatinib—Back pain—Lisinopril—dilated cardiomyopathy	0.000348	0.0108	CcSEcCtD
Lapatinib—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00034	0.0106	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000338	0.0105	CcSEcCtD
Lapatinib—Fatigue—Furosemide—dilated cardiomyopathy	0.000337	0.0105	CcSEcCtD
Lapatinib—Constipation—Furosemide—dilated cardiomyopathy	0.000334	0.0104	CcSEcCtD
Lapatinib—Anaemia—Lisinopril—dilated cardiomyopathy	0.000332	0.0103	CcSEcCtD
Lapatinib—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000322	0.01	CcSEcCtD
Lapatinib—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00032	0.00994	CcSEcCtD
Lapatinib—Palpitations—Lisinopril—dilated cardiomyopathy	0.000318	0.00988	CcSEcCtD
Lapatinib—Cough—Lisinopril—dilated cardiomyopathy	0.000314	0.00975	CcSEcCtD
Lapatinib—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000309	0.00961	CcSEcCtD
Lapatinib—Myalgia—Lisinopril—dilated cardiomyopathy	0.000306	0.00952	CcSEcCtD
Lapatinib—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000306	0.00952	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000304	0.00945	CcSEcCtD
Lapatinib—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000293	0.00912	CcSEcCtD
Lapatinib—Infection—Lisinopril—dilated cardiomyopathy	0.000292	0.00906	CcSEcCtD
Lapatinib—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000288	0.00896	CcSEcCtD
Lapatinib—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000285	0.00886	CcSEcCtD
Lapatinib—Asthenia—Furosemide—dilated cardiomyopathy	0.000281	0.00872	CcSEcCtD
Lapatinib—Anorexia—Lisinopril—dilated cardiomyopathy	0.00028	0.0087	CcSEcCtD
Lapatinib—Pruritus—Furosemide—dilated cardiomyopathy	0.000277	0.0086	CcSEcCtD
Lapatinib—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000268	0.00832	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000267	0.00831	CcSEcCtD
Lapatinib—Insomnia—Lisinopril—dilated cardiomyopathy	0.000265	0.00825	CcSEcCtD
Lapatinib—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000262	0.00813	CcSEcCtD
Lapatinib—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000258	0.00803	CcSEcCtD
Lapatinib—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000255	0.00793	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000253	0.00788	CcSEcCtD
Lapatinib—Fatigue—Lisinopril—dilated cardiomyopathy	0.000253	0.00786	CcSEcCtD
Lapatinib—Constipation—Lisinopril—dilated cardiomyopathy	0.000251	0.0078	CcSEcCtD
Lapatinib—Vomiting—Furosemide—dilated cardiomyopathy	0.000249	0.00773	CcSEcCtD
Lapatinib—Rash—Furosemide—dilated cardiomyopathy	0.000247	0.00767	CcSEcCtD
Lapatinib—Dermatitis—Furosemide—dilated cardiomyopathy	0.000246	0.00766	CcSEcCtD
Lapatinib—Headache—Furosemide—dilated cardiomyopathy	0.000245	0.00762	CcSEcCtD
Lapatinib—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00024	0.00746	CcSEcCtD
Lapatinib—Nausea—Furosemide—dilated cardiomyopathy	0.000232	0.00722	CcSEcCtD
Lapatinib—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000232	0.00721	CcSEcCtD
Lapatinib—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000216	0.00672	CcSEcCtD
Lapatinib—Asthenia—Lisinopril—dilated cardiomyopathy	0.000211	0.00654	CcSEcCtD
Lapatinib—Pruritus—Lisinopril—dilated cardiomyopathy	0.000208	0.00645	CcSEcCtD
Lapatinib—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000201	0.00624	CcSEcCtD
Lapatinib—Vomiting—Lisinopril—dilated cardiomyopathy	0.000187	0.0058	CcSEcCtD
Lapatinib—Rash—Lisinopril—dilated cardiomyopathy	0.000185	0.00575	CcSEcCtD
Lapatinib—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000185	0.00575	CcSEcCtD
Lapatinib—Headache—Lisinopril—dilated cardiomyopathy	0.000184	0.00571	CcSEcCtD
Lapatinib—Nausea—Lisinopril—dilated cardiomyopathy	0.000174	0.00542	CcSEcCtD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000101	0.00096	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	0.000101	0.00096	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.0001	0.000951	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.0001	0.000951	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—RAC1—dilated cardiomyopathy	0.0001	0.00095	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.0001	0.00095	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—EGFR—dilated cardiomyopathy	9.87e-05	0.000935	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	9.84e-05	0.000932	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	9.6e-05	0.00091	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—EGFR—dilated cardiomyopathy	9.57e-05	0.000907	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	9.52e-05	0.000903	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—EGFR—dilated cardiomyopathy	9.52e-05	0.000903	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.52e-05	0.000903	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—RAF1—dilated cardiomyopathy	9.5e-05	0.0009	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—EGFR—dilated cardiomyopathy	9.48e-05	0.000898	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—RAC1—dilated cardiomyopathy	9.43e-05	0.000894	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	9.43e-05	0.000894	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—EGFR—dilated cardiomyopathy	9.43e-05	0.000894	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—EGFR—dilated cardiomyopathy	9.43e-05	0.000893	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.39e-05	0.00089	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—EGFR—dilated cardiomyopathy	9.38e-05	0.000889	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—EGFR—dilated cardiomyopathy	9.34e-05	0.000885	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	9.3e-05	0.000881	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—EGFR—dilated cardiomyopathy	9.29e-05	0.00088	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	9.26e-05	0.000877	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	9.16e-05	0.000868	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—GPX1—dilated cardiomyopathy	9.14e-05	0.000866	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—CD36—dilated cardiomyopathy	9.11e-05	0.000863	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	9.06e-05	0.000858	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.05e-05	0.000858	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.04e-05	0.000857	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ITGB1—dilated cardiomyopathy	8.92e-05	0.000845	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—RAC1—dilated cardiomyopathy	8.91e-05	0.000845	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CD36—dilated cardiomyopathy	8.9e-05	0.000843	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.88e-05	0.000841	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	8.87e-05	0.000841	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—EGFR—dilated cardiomyopathy	8.87e-05	0.000841	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	8.87e-05	0.000841	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GPX1—dilated cardiomyopathy	8.83e-05	0.000836	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—RAF1—dilated cardiomyopathy	8.81e-05	0.000835	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—EGFR—dilated cardiomyopathy	8.81e-05	0.000835	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—EGFR—dilated cardiomyopathy	8.79e-05	0.000833	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—EGFR—dilated cardiomyopathy	8.74e-05	0.000828	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	8.74e-05	0.000828	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	8.74e-05	0.000828	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	8.72e-05	0.000826	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—RAF1—dilated cardiomyopathy	8.68e-05	0.000823	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—EGFR—dilated cardiomyopathy	8.68e-05	0.000822	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—EGFR—dilated cardiomyopathy	8.66e-05	0.000821	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—CD36—dilated cardiomyopathy	8.59e-05	0.000814	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	8.58e-05	0.000814	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—RAC1—dilated cardiomyopathy	8.58e-05	0.000813	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—EGFR—dilated cardiomyopathy	8.55e-05	0.00081	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.5e-05	0.000806	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—EGFR—dilated cardiomyopathy	8.38e-05	0.000794	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NPPA—dilated cardiomyopathy	8.37e-05	0.000793	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.35e-05	0.000791	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—PSEN2—dilated cardiomyopathy	8.25e-05	0.000782	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NPPA—dilated cardiomyopathy	8.25e-05	0.000781	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—EGFR—dilated cardiomyopathy	8.21e-05	0.000778	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PSEN2—dilated cardiomyopathy	8.11e-05	0.000768	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—EGFR—dilated cardiomyopathy	8.09e-05	0.000766	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD36—dilated cardiomyopathy	8.05e-05	0.000762	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AGT—dilated cardiomyopathy	8.01e-05	0.000759	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PSEN2—dilated cardiomyopathy	7.99e-05	0.000757	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—RAF1—dilated cardiomyopathy	7.98e-05	0.000756	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.95e-05	0.000753	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD36—dilated cardiomyopathy	7.92e-05	0.000751	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	7.86e-05	0.000745	CbGpPWpGaD
Lapatinib—TAP1—Immune System—RAF1—dilated cardiomyopathy	7.79e-05	0.000738	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	7.74e-05	0.000734	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AGT—dilated cardiomyopathy	7.74e-05	0.000733	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD36—dilated cardiomyopathy	7.73e-05	0.000732	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	7.71e-05	0.000731	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD36—dilated cardiomyopathy	7.61e-05	0.000721	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—RAC1—dilated cardiomyopathy	7.58e-05	0.000718	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	7.5e-05	0.000711	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—RAC1—dilated cardiomyopathy	7.47e-05	0.000708	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—RAC1—dilated cardiomyopathy	7.28e-05	0.00069	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—ITGB1—dilated cardiomyopathy	7.24e-05	0.000686	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	7.18e-05	0.00068	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	7.18e-05	0.00068	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—RAC1—dilated cardiomyopathy	7.17e-05	0.00068	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	7.07e-05	0.00067	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—RAF1—dilated cardiomyopathy	6.75e-05	0.000639	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—RAF1—dilated cardiomyopathy	6.71e-05	0.000636	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	6.71e-05	0.000636	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—RAF1—dilated cardiomyopathy	6.68e-05	0.000633	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—RAF1—dilated cardiomyopathy	6.65e-05	0.00063	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	6.52e-05	0.000618	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—RAC1—dilated cardiomyopathy	6.43e-05	0.000609	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—RAF1—dilated cardiomyopathy	6.26e-05	0.000593	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	6.26e-05	0.000593	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	6.26e-05	0.000593	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—RAF1—dilated cardiomyopathy	6.2e-05	0.000587	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	6.14e-05	0.000582	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—RAF1—dilated cardiomyopathy	6.12e-05	0.00058	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—EGFR—dilated cardiomyopathy	6.04e-05	0.000573	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.98e-05	0.000567	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—EGFR—dilated cardiomyopathy	5.95e-05	0.000564	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—RAF1—dilated cardiomyopathy	5.91e-05	0.00056	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.89e-05	0.000558	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.82e-05	0.000551	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.82e-05	0.000551	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—RAC1—dilated cardiomyopathy	5.82e-05	0.000551	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—RAF1—dilated cardiomyopathy	5.69e-05	0.000539	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.68e-05	0.000538	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—dilated cardiomyopathy	5.65e-05	0.000535	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.59e-05	0.00053	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	5.54e-05	0.000525	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ITGB1—dilated cardiomyopathy	5.49e-05	0.000521	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—EGFR—dilated cardiomyopathy	5.47e-05	0.000518	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ITGB1—dilated cardiomyopathy	5.41e-05	0.000513	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.41e-05	0.000512	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	5.35e-05	0.000507	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EGFR—dilated cardiomyopathy	5.34e-05	0.000506	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	5.21e-05	0.000494	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ITGB1—dilated cardiomyopathy	5.16e-05	0.000489	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.04e-05	0.000478	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.04e-05	0.000478	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—RAF1—dilated cardiomyopathy	5.03e-05	0.000476	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.97e-05	0.000471	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.97e-05	0.000471	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—RAF1—dilated cardiomyopathy	4.95e-05	0.000469	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	4.9e-05	0.000464	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—RAF1—dilated cardiomyopathy	4.83e-05	0.000457	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—RAF1—dilated cardiomyopathy	4.76e-05	0.000451	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.74e-05	0.000449	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.69e-05	0.000444	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD36—dilated cardiomyopathy	4.69e-05	0.000444	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.62e-05	0.000437	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD36—dilated cardiomyopathy	4.62e-05	0.000437	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.57e-05	0.000433	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.54e-05	0.00043	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.51e-05	0.000428	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.48e-05	0.000425	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.47e-05	0.000424	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	4.43e-05	0.00042	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—RAC1—dilated cardiomyopathy	4.42e-05	0.000418	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CD36—dilated cardiomyopathy	4.4e-05	0.000417	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ITGB1—dilated cardiomyopathy	4.38e-05	0.000415	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—RAC1—dilated cardiomyopathy	4.35e-05	0.000412	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—RAF1—dilated cardiomyopathy	4.26e-05	0.000404	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	4.26e-05	0.000404	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	4.24e-05	0.000402	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—RAC1—dilated cardiomyopathy	4.15e-05	0.000393	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.13e-05	0.000391	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.13e-05	0.000391	CbGpPWpGaD
Lapatinib—ERBB2—Disease—RAC1—dilated cardiomyopathy	4.08e-05	0.000386	CbGpPWpGaD
Lapatinib—EGFR—Disease—NPPA—dilated cardiomyopathy	4.05e-05	0.000384	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.03e-05	0.000382	CbGpPWpGaD
Lapatinib—ERBB4—Disease—RAC1—dilated cardiomyopathy	4.02e-05	0.000381	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.93e-05	0.000373	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.93e-05	0.000372	CbGpPWpGaD
Lapatinib—EGFR—Disease—PSEN2—dilated cardiomyopathy	3.92e-05	0.000371	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—dilated cardiomyopathy	3.9e-05	0.00037	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD36—dilated cardiomyopathy	3.89e-05	0.000369	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.88e-05	0.000367	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—RAF1—dilated cardiomyopathy	3.86e-05	0.000365	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.84e-05	0.000364	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.84e-05	0.000363	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.84e-05	0.000363	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.82e-05	0.000362	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.79e-05	0.000359	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD36—dilated cardiomyopathy	3.73e-05	0.000354	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—dilated cardiomyopathy	3.72e-05	0.000352	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.71e-05	0.000352	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.7e-05	0.00035	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.68e-05	0.000348	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RAC1—dilated cardiomyopathy	3.67e-05	0.000347	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.62e-05	0.000343	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RAC1—dilated cardiomyopathy	3.52e-05	0.000334	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—dilated cardiomyopathy	3.45e-05	0.000327	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.42e-05	0.000324	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—dilated cardiomyopathy	3.4e-05	0.000322	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.34e-05	0.000317	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.31e-05	0.000314	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.26e-05	0.000309	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.17e-05	0.000301	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.16e-05	0.000299	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.11e-05	0.000295	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.01e-05	0.000285	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.97e-05	0.000282	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—RAF1—dilated cardiomyopathy	2.93e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—RAF1—dilated cardiomyopathy	2.88e-05	0.000273	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.86e-05	0.000271	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RAC1—dilated cardiomyopathy	2.81e-05	0.000266	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—RAF1—dilated cardiomyopathy	2.75e-05	0.000261	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.74e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AGT—dilated cardiomyopathy	2.73e-05	0.000258	CbGpPWpGaD
Lapatinib—ERBB2—Disease—RAF1—dilated cardiomyopathy	2.7e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AGT—dilated cardiomyopathy	2.69e-05	0.000255	CbGpPWpGaD
Lapatinib—ERBB4—Disease—RAF1—dilated cardiomyopathy	2.66e-05	0.000252	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ITGB1—dilated cardiomyopathy	2.66e-05	0.000252	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.44e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.44e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RAF1—dilated cardiomyopathy	2.43e-05	0.00023	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.42e-05	0.000229	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.34e-05	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.34e-05	0.000221	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.33e-05	0.000221	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.28e-05	0.000216	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.28e-05	0.000216	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.27e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD36—dilated cardiomyopathy	2.27e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AGT—dilated cardiomyopathy	2.23e-05	0.000212	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.19e-05	0.000208	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RAC1—dilated cardiomyopathy	2.13e-05	0.000202	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.09e-05	0.000198	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.06e-05	0.000195	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.05e-05	0.000194	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.04e-05	0.000193	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.03e-05	0.000193	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—dilated cardiomyopathy	2.01e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—dilated cardiomyopathy	1.98e-05	0.000187	CbGpPWpGaD
Lapatinib—EGFR—Disease—RAC1—dilated cardiomyopathy	1.97e-05	0.000187	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.94e-05	0.000184	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.89e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.87e-05	0.000178	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.86e-05	0.000177	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—dilated cardiomyopathy	1.85e-05	0.000176	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.83e-05	0.000174	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—dilated cardiomyopathy	1.83e-05	0.000173	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—dilated cardiomyopathy	1.8e-05	0.00017	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.78e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.55e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.53e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RAF1—dilated cardiomyopathy	1.42e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	0.000131	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGT—dilated cardiomyopathy	1.32e-05	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Disease—RAF1—dilated cardiomyopathy	1.31e-05	0.000124	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.3e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.28e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.2e-05	0.000114	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.18e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.17e-05	0.000111	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.05e-05	0.0001	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.04e-05	9.87e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.01e-05	9.62e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	9.3e-06	8.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RAF1—dilated cardiomyopathy	9.15e-06	8.67e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	9.14e-06	8.66e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	9.08e-06	8.6e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	9.06e-06	8.58e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CD36—dilated cardiomyopathy	8.84e-06	8.38e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	8.16e-06	7.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.96e-06	7.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.59e-06	5.3e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.45e-06	5.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.9e-06	4.65e-05	CbGpPWpGaD
